COX and PPAR - Possible interactions in pancreatic cancer

被引：10
作者：
Eibl, G
Reber, HA
Hines, OJ
Go, VLW
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Sect Gastrointestinal Surg,Hirshberg Pancreat Can, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA USA
来源：
PANCREAS | 2004年 / 29卷 / 04期
关键词：
D O I：
10.1097/00006676-200411000-00002
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：247 / 253
页数：7
相关论文
共 112 条
[1]   Arachidonic acid differentially affects basal and lipopolysaccharide-induced sPLA2-IIA expression in alveolar macrophages through NF-κB and PPAR-γ-dependent pathways [J].
Alaoui-El-Azher, M ;
Wu, YZ ;
Havet, N ;
Israël, A ;
Lilienbaum, A ;
Touqui, L .
MOLECULAR PHARMACOLOGY, 2002, 61 (04) :786-794
[2]  
Anderson KE, 2002, J NATL CANCER I, V94, P1168, DOI 10.1093/jnci/94.15.1168
[3]  
Aoki T, 2002, ONCOL REP, V9, P761
[4]   COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression [J].
Chandrasekharan, NV ;
Dai, H ;
Roos, KLT ;
Evanson, NK ;
Tomsik, J ;
Elton, TS ;
Simmons, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) :13926-13931
[5]  
Chu JS, 2003, MOL CANCER THER, V2, P1
[6]   15-deoxy-Δ12,14PGJ2 induces diverse biological responses via PPARγ activation in cancer cells [J].
Clay, CE ;
Namen, AM ;
Fonteh, AN ;
Atsumi, G ;
High, KP ;
Chilton, FH .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2000, 62 (01) :23-32
[7]   Magnitude of peroxisome proliferator-activated receptor-γ activation is associated with important and seemingly opposite biological responses in breast cancer cells [J].
Clay, CE ;
Namen, AM ;
Atsumi, G ;
Trimboli, AJ ;
Fonteh, AN ;
High, KP ;
Chilton, FH .
JOURNAL OF INVESTIGATIVE MEDICINE, 2001, 49 (05) :413-420
[8]   Interleukin 1β induces type II-secreted phospholipase A2 gene in vascular smooth muscle cells by a nuclear factor κB and peroxisome proliferator-activated receptor-mediated process [J].
Couturier, C ;
Brouillet, A ;
Couriaud, C ;
Koumanov, K ;
Béréziat, G ;
Andréani, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (33) :23085-23093
[9]  
Crosby Colin G, 2003, Expert Opin Emerg Drugs, V8, P1
[10]   Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer [J].
Dannenberg, AJ ;
Altorki, NK ;
Boyle, JO ;
Dang, C ;
Howe, LR ;
Weksler, BB ;
Subbararnaiah, K .
LANCET ONCOLOGY, 2001, 2 (09) :544-551
12345678910